Podcast: The future of the cannabis industry and what investors should expect
Market research company Brightfield Group expects the cannabis industry in Canada to grow to $3.7 billion in 2020 compared to $1.6 billion in 2019.
Brightfield expects Cannabis 2.0 product sales to contribute $900 million this year, including cannabis-infused edibles, beverages, and vapes.
At the forefront of cannabis health product in Canada is Embark Health
Here to speak with Finfeed today about the ups and downs of the cannabis industry, cannabis in Canada and what he sees is the future of the cannabis industry is COO and director of Embark Health, Mike Curtis. Mike is an experienced former investment banker and private equity executive, who is now an active cannabis sector executive.
View Our Investment Portfolios
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction
is established and have entered into a growth phase.
Like this article? You may like...
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
Publishers Notice
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.
